Document 0262 DOCN M9650262 TI [Selective inhibition of replication of human cytomegalovirus by desferrioxamine in vitro and in vivo (case report)] DT 9605 AU Gumbel H; Cinatl J Jr; Rabenau H; Vogel JU; Doerr HW; Ohrloff C; Zentrum der Augenheilkunde, Universitat Frankfurt/Main. SO Ophthalmologe. 1995 Dec;92(6):840-3. Unique Identifier : AIDSLINE MED/96147378 AB In AIDS patients cytomegalovirus (HCMV) retinitis is one of the most frequent opportunistic infections. Antiviral therapy aims at preserving vision as long as possible, but more and more HCMV isolates are proving to be resistant to ganciclovir (GCV) and foscarnet (PFA) in vitro. We tested whether desferrioxamine (DFO), an iron chelator with antiherpetic activity, can inhibit clinical virus isolates and laboratory strains. Clinical isolates were obtained from urine samples of AIDS patients with HCMV retinitis. The concentrations of DFO required for 50% and 90% reduction of the production of HCMV in several HCMV strains ranged from 3.1 to 4.9 microns and from 14.2 to 17.3 microns, respectively, Inhibitory effects of DFO on HCMV replication were completely prevented by co-incubation with stoichiometric amounts of FE3+. CASE REPORTS: DFO was administered by daily dose of 1 g i.v. to a patient with AIDS in whom HCMV retinitis continued to progress despite combination therapy with GCV and PFA. The addition of DFO to the combination inhibited progression of the disease. No relapse of HCMV retinitis was seen with 3 months of DFO therapy. The treatment was free of side effects. DE Adult Antiviral Agents/ADMINISTRATION & DOSAGE AIDS-Related Opportunistic Infections/*DRUG THERAPY/VIROLOGY Case Report Cytomegalovirus/*DRUG EFFECTS Cytomegalovirus Retinitis/*DRUG THERAPY/VIROLOGY Deferoxamine/*ADMINISTRATION & DOSAGE Dose-Response Relationship, Drug English Abstract Ganciclovir/ADMINISTRATION & DOSAGE Human Infusions, Intravenous Male Siderophores/*ADMINISTRATION & DOSAGE Virus Cultivation Virus Replication/*DRUG EFFECTS JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).